To determine how mutations other than those in the ABL1 gene affect chronic myeloid leukemia (CML) prognosis, researchers identified 115 patients with CML where targeted next-generation sequencing of genes recurrently mutated in myeloid leukemias was performed.
[Blood Cancer Journal]